WO2019112562A1 - Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch - Google Patents
Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch Download PDFInfo
- Publication number
- WO2019112562A1 WO2019112562A1 PCT/US2017/064677 US2017064677W WO2019112562A1 WO 2019112562 A1 WO2019112562 A1 WO 2019112562A1 US 2017064677 W US2017064677 W US 2017064677W WO 2019112562 A1 WO2019112562 A1 WO 2019112562A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pet food
- food composition
- animal
- resistant starch
- extruded
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 185
- 239000000203 mixture Substances 0.000 title claims abstract description 162
- 229920000294 Resistant starch Polymers 0.000 title claims abstract description 89
- 235000021254 resistant starch Nutrition 0.000 title claims abstract description 89
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 241001465754 Metazoa Species 0.000 claims abstract description 95
- 238000001125 extrusion Methods 0.000 claims abstract description 76
- 238000000034 method Methods 0.000 claims abstract description 49
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 10
- 241000186660 Lactobacillus Species 0.000 claims abstract description 9
- 230000003247 decreasing effect Effects 0.000 claims abstract description 8
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 8
- 241000043362 Megamonas Species 0.000 claims abstract description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 26
- 239000002994 raw material Substances 0.000 claims description 21
- PGSWEKYNAOWQDF-UHFFFAOYSA-N 3-methylcatechol Chemical compound CC1=CC=CC(O)=C1O PGSWEKYNAOWQDF-UHFFFAOYSA-N 0.000 claims description 14
- 230000007423 decrease Effects 0.000 claims description 14
- NWBBWUXCVIJZBG-UHFFFAOYSA-N 4-(2-aminoethyl)benzene-1,2-diol;sulfuric acid Chemical compound OS(O)(=O)=O.NCCC1=CC=C(O)C(O)=C1 NWBBWUXCVIJZBG-UHFFFAOYSA-N 0.000 claims description 13
- 240000007594 Oryza sativa Species 0.000 claims description 10
- 235000007164 Oryza sativa Nutrition 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000009566 rice Nutrition 0.000 claims description 10
- VTYFITADLSVOAS-NSHDSACASA-N 1-(L-norleucin-6-yl)pyrraline Chemical compound OC(=O)[C@@H](N)CCCCN1C(CO)=CC=C1C=O VTYFITADLSVOAS-NSHDSACASA-N 0.000 claims description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- 108010087806 Carnosine Proteins 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 5
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 5
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 5
- 229940044199 carnosine Drugs 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 abstract description 23
- 230000036541 health Effects 0.000 abstract description 16
- 230000009286 beneficial effect Effects 0.000 abstract description 15
- 230000008569 process Effects 0.000 abstract description 11
- 230000002939 deleterious effect Effects 0.000 abstract description 10
- 230000002496 gastric effect Effects 0.000 abstract description 8
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 235000021195 test diet Nutrition 0.000 description 61
- 235000020940 control diet Nutrition 0.000 description 45
- 241000282465 Canis Species 0.000 description 24
- 241000282472 Canis lupus familiaris Species 0.000 description 22
- 229920002472 Starch Polymers 0.000 description 19
- 235000019698 starch Nutrition 0.000 description 18
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 16
- 238000002156 mixing Methods 0.000 description 13
- 239000008107 starch Substances 0.000 description 13
- 230000002550 fecal effect Effects 0.000 description 12
- 239000000835 fiber Substances 0.000 description 12
- 239000002207 metabolite Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 9
- 235000019621 digestibility Nutrition 0.000 description 8
- 229960003638 dopamine Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000002441 uremic toxin Substances 0.000 description 8
- 241000736262 Microbiota Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 241000894007 species Species 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000000112 colonic effect Effects 0.000 description 3
- 230000001627 detrimental effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000021312 gluten Nutrition 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 150000003893 lactate salts Chemical class 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 208000015122 neurodegenerative disease Diseases 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- NUXSIDPKKIEIMI-LURJTMIESA-N N(6)-carboxymethyl-L-lysine Chemical compound OC(=O)[C@@H](N)CCCCNCC(O)=O NUXSIDPKKIEIMI-LURJTMIESA-N 0.000 description 2
- ZUASNUUDNPNMAT-UHFFFAOYSA-N N6-Carboxymethyl-Lysine Natural products COC(=O)NCCCCC(N)C(O)=O ZUASNUUDNPNMAT-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036765 blood level Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- OQVWLUCZSGSDLP-MLWJPKLSSA-N (2S)-2-amino-6-(carboxyamino)-3-ethylhexanoic acid Chemical compound C(=O)(O)NCCCC([C@H](N)C(=O)O)CC OQVWLUCZSGSDLP-MLWJPKLSSA-N 0.000 description 1
- UENLDOJJKXLRJI-ZETCQYMHSA-N (2s)-6-amino-2-(2-carboxyethylamino)hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NCCC(O)=O UENLDOJJKXLRJI-ZETCQYMHSA-N 0.000 description 1
- RRUYWEMUWIRRNB-LURJTMIESA-N (2s)-6-amino-2-[carboxy(methyl)amino]hexanoic acid Chemical compound OC(=O)N(C)[C@H](C(O)=O)CCCCN RRUYWEMUWIRRNB-LURJTMIESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- JVGVDSSUAVXRDY-UHFFFAOYSA-M 3-(4-hydroxyphenyl)lactate Chemical compound [O-]C(=O)C(O)CC1=CC=C(O)C=C1 JVGVDSSUAVXRDY-UHFFFAOYSA-M 0.000 description 1
- VOXXWSYKYCBWHO-UHFFFAOYSA-M 3-phenyllactate Chemical compound [O-]C(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-M 0.000 description 1
- KKADPXVIOXHVKN-UHFFFAOYSA-N 4-hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=C(O)C=C1 KKADPXVIOXHVKN-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000605716 Desulfovibrio Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 239000004344 EU approved packaging gas Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000920592 Red seabream iridovirus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 230000007149 gut brain axis pathway Effects 0.000 description 1
- 230000007412 host metabolism Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000008798 inflammatory stress Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- KXFJZKUFXHWWAJ-UHFFFAOYSA-N p-hydroxybenzoylformic acid Natural products OC(=O)C(=O)C1=CC=C(O)C=C1 KXFJZKUFXHWWAJ-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Definitions
- Pet food compositions such as dog and cat food compositions, may provide health and nutritional benefits to the companion animals that consume them.
- pet food compositions are formed by an extrusion process, in which the raw material ingredients are extruded in an extrusion device under varying conditions of heat and pressure to yield the desired form.
- the raw material ingredients are typically subjected to high shear mixing forces, which result in a break-down of the starch in the raw materials. As the starch breaks down, it becomes more readily digestible by the consuming animal.
- the starch is not absorbed or digested in the stomach or small intestine, it is known as a resistant starch. Resistant starches then enter the lower gastrointestinal tract of animals where they may be digested by microbiota that reside in the large intestine. Resistant starches have several health benefits, such as maintaining or improving the proportion of beneficial bacteria in relation to deleterious bacteria in the gastrointestinal tract of animals. Accordingly, a pet food composition comprising an enhanced level of resistant starches and a method of making a pet food composition comprising an enhanced level of resistant starches would be beneficial to companion animals and their caregivers.
- a pet food composition that maintains or improves the proportion of beneficial bacteria in relation to deleterious bacteria in the gastrointestinal tract of animals and a method of maintaining or improving the proportion of beneficial bacteria in relation to deleterious bacteria would be advantageous to animals, such as aging or senior animals.
- extruded pet food compositions comprising resistant starch in an amount of at least about 7%, such as about 7% to about 30%, at least about 10%, about 7% to about 20%, about 9% to about 13%, or about 20% to about 30%, by weight based on the total weight of the extruded pet food composition.
- a source of the resistant starch in the extruded pet food composition is at least one of com, such as whole com, and rice, such as brewer’s rice.
- the sole source of resistant starch in the extruded pet food composition is at least one of corn, such as whole corn, and rice, such as brewer’s rice.
- the extruded pet food composition may be in the form of a kibble, and in certain embodiments the extruded pet food composition may be in the form of a treat or snack. According to certain embodiments, the extruded pet food composition may be a dog food.
- a pet food composition made by a method comprising providing pet food raw' materials for extrusion and extruding said pet food raw materials using an extrusion device, wherein a sum of the specific mechanical energy and the specific thermal energy of the extrusion device is less than about 60 Wh/kg, wherein the ratio of specific mechanical energy to specific thermal energy is less than 0 5, and wherein the extruded pet food composition comprises resistant starch in an amount of at least about 7% by weight based on the total weight of the pet food composition.
- a pet food composition made by the method disclosed herein comprises resistant starch in an amount ranging from about 7% to about 30%, or at least about 10%, or, in certain embodiments, ranging from about 7% to about 20%, such as from about 9% to about 13%, by weight based on the total weight of the pet food composition.
- the pet food composition made by the methods disclosed herein may be in the form of a kibble, and in certain embodiments, may be in the form of a treat or snack. According to certain embodiments, the pet food compositions made by the methods disclosed herein may be a dog food.
- a pet food composition made by a method comprising providing pet food raw materials for extrusion and extruding the pet food raw materials using an extrusion device, wherein a specifi c mechanical energy of the extrusion device is less than about 25 Wh/kg, wherein the extruded pet food composition comprises resistant starch in an amount of at least about 7% by weight based on the total weight of the pet food composition, and wherein the amount of at least one of N6-carboxy 3-methy!ly ine, N6-carboxy 3-ethyl lysine, or pyrraline decreases in an animal who consumes the pet food composition.
- the amount of camosine increases in an animal who consumes the pet food compositions, and, in certain embodiments, the levels of dopamine sulfate increase in an animal who consumes the pet food composition.
- the amount of 3 -methyl catechol sulfate decreases in an animal who consumes the pet food composition.
- Lactobacillus and Bifidobacterium in the gastrointestinal tract of an animal comprising administering a pet food composition to the animal, wherein the pet food composition comprises resistant starch in an amount of at least about 7%, such as about 7% to about 30%, at least about 10%, about 9% to about 13%, or about 7% to about 20%, by weight based on the total weight of the pet food composition.
- the pet food composition is made by the method comprising providing pet food raw materials for extrusion; and extruding said pet food raw materials using an extrusion device; wherein the total specific mechanical energy of the extrusion device is less than 25 W h/kg and wherein the extruded pet food composition comprises resistant starch in an amount of at least about 7% by weight based on the total weight of the pet food composition; and wherein the animal consumes at least about 2.5 g of the resistant starch per kg of animal per day
- Lactobacillus and Bifidobacterium further comprises decreasing the proportion of Megamonas in the gastrointestinal tract of the animal.
- the animal is a senior animal, and in certain embodiments, the animal is a dog.
- Also disclosed herein is a method of making a pet food composition
- a method of making a pet food composition comprising providing pet food raw materials for extrusion and extruding the pet food raw materials using an extrusion device, wherein a specific mechanical energy of the extrusion device is less than about 25 W h/kg, and wherein the extruded pet food composition comprises resistant starch in an amount of at least about 7% by weight based on the total weight of the pet food composition.
- the amount of resistant starch ranges from about 9% to about 13% by weight based on the total weight of the pet food composition.
- a specific thermal energy of the extrusion device is greater than the specific mechanical energy of the extrusion device.
- the specific thermal energy of the extrusion device is about four times greater than the specific mechanical energy of the extrusion device.
- Figure 1 is a graph showing the Relative Viscosity Analysis for a sample of Test Diet prepared under low shear extrusion conditions having an enhanced amount of resistant starch and versus a Control Diet prepared under high shear extrusion conditions.
- the resistant starch peak of the Test Diet is noted with an arrow.
- Figure 2 is a graph indicating the fecal levels of the following analytes in terms of least square group means in canines who consumed a Test Diet prepared under low shear extrusion conditions versus canines who consumed a Control Diet prepared under high shear extrusion conditions: lactate, pyruvate, phenyllactate, phenyl pryuvate, 4-hydroxyphenyllactate, and 4- hydroxyphenylpyruvate.
- Figure 3 is a graph showing the mass in grams of returned kibble from canine subjects offered the Test Diet and canine subjects offered the Control Diet.
- the term“or” is an inclusive operator, and is equivalent to the term “and/or,” unless the context clearly dictates otherwise.
- the term“based on” is not exclusive and allows for being based on additional factors not described, unless the context clearly dictates otherwise.
- the recitation of “at least one of A, B, and C,” includes embodiments containing A, B, or C, multiple examples of A, B, or C, or combinations of A/B, A/C, B/C, A/B/B / B/B/C, A/B/C, etc.
- the meaning of “a,”“an,” and“the” include plural references.
- the meaning of“in” includes“in” and“on.”
- first, second, etc. may be used herein to describe various elements, these elements should not be limited bv these terms. These terms are only used to distinguish one element from another.
- a. first object, component, or step could be termed a second object, component, or step, and, similarly, a second object, component, or step could be termed a first object, component, or step, without departing from the scope of the invention.
- the first object, component, or step, and the second object, component, or step are both, objects, component, or steps, respectively, but they are not to be considered the same object, component, or step.
- the term“if’ may be construed to mean“when” or“upon” or“in response to determining” or“in response to detecting,” depending on the context.
- any numerical range of values herein are understood to include each and every number and/or fraction between the stated range minimum and maximum, as well as the endpoints.
- a range of 0 5-6% would expressly include all intermediate values of, for example, 0.6%, 0.7%, and 0.9%, all the way up to and including 5.95%, 5 97%, and 5.99%, among many others.
- ail numerical values are "about” or “approximately” the indicated value, and take into account experimental error and variations that would be expected by a person having ordinary skill in the art.. It should be appreciated that all numerical values and ranges disclosed herein are approximate values and ranges, whether "about” is used in conjunction therewith.
- compositions and methods for making pet food compositions comprising an enhanced amount of resistant starch are disclosed herein. Further disclosed herein are methods for maintaining the gastrointestinal health of a companion animal, such as dog, by feeding the companion animal a pet food composition as disclosed herein.
- the compositions and methods disclosed herein are based, in part, on the discovery that administration of compositions comprising enhanced levels of resistant starch can improve the gastrointestinal health of a mammal, such as a companion animal.
- Companion animals include, for example, dogs, cats, rabbits, and horses
- resistant starch refers to starches and products of starch digestion that are not absorbed in the stomach or small intestine of mammals, but rather enter into the large intestine for digestion. Once in the large intestine, resistant starches may be fermented by microflora that is either resident naturally or introduced via diet, such as in the form of probiotics. Resistant starches may be categorized into at least five different groups, ranging fro RSI to RSV.
- the categories of resistant starches include: (1) physically inaccessible starches (RSI), which include, for example, intact or partly milled grains and seeds, such as intact whole grains; (2) resistant native starches (RSII), which include, for example, raw potato, green banana, certain legumes, and high amylose maize; (3) retrograded starches (RSIII), which include, for example, cooked and cooled starchy foods, such as recrystallized maize or tapioca starch; (4) chemically modified starches (RSIV), which include, for example, starch ethers and esters cross-bonded starches, such as sodium trimetaphosphate (STMP)/sodiunipolyphosphate (STPP) cross-linked wheat starch, and (5) starch-lipid inclusion complexes (RSV), which include, for example, cooked, gelled, extruded starch in the presence of lipids, including polar lipids.
- RSI physically inaccessible starches
- RSII resistant native starches
- RSIII retrograde
- Resistant starches encompass all resistant starches including those derived from native and non-native sources.
- the resistant starches in the compositions disclosed herein may originate from a variety of different starch sources.
- the resistant starches may originate from at least one of corn, such as whole core, rice, such as brewer’s rice; wheat; barley; soy; and oats and flours thereof.
- the sole source of the resistant starch for the compositions disclosed herein may be at least one com, such as whole corn, and rice, such as brewer’s rice.s
- resistant starches are not digestible by the stomach or small intestine, they pass through an animal into the large intestine of the gastrointestinal tract, where the resistant starch may be fermented or digested by various microbiota species.
- the community of bacteria resident in the gastrointestinal tract comprises beneficial, deleterious, and inconsequential bacterial types or species. Whether a particular member of the digestive tract flora is beneficial, deleterious, or inconsequential to the health of the animal in particular circumstances can depend on a number of factors. Examples of beneficial members of the digestive tract flora include bifidobacteria, species of the genus Bifidobacterium , and lactic acid bacteria, species of the genus Lactobacillus.
- Deleterious bacteria include pathogenic bacteria, such as Megamonas, Clostridium , Desulfovibrio, Helicobacter , and pathogenic forms of Escherichia coli. Gastrointestinal health typically depends on the maintenance of an appropriate balance of beneficial and deleterious bacteria. Accordingly, an increase in the population of beneficial bacteria and/or a decrease in the population of deleterious bacteria can be associated with an improvement in gastrointestinal health.
- a pet food composition compri sing enhanced levels of resistant starch, such as a pet food composition comprising resistant starch in an amount of at least about 7% by weight based on the total weight of the pet food composition.
- the pet food composition disclosed herein may comprise, for example, at least about 9% resistant starch, at least about 10% resistant starch, at least about 15% resistant starch, at least about 20% resistant starch, at least about 25% resistant starch, or at least about 30% resistant starch, by weight based on the total weight of the pet food composition.
- the pet food composition disclosed herein may comprise a range of from about 7% to about 30%, such as from about 7% to about 20% or about 9% to about 13% resistant starch, by weight based on the total weight of the pet food composition.
- the enhanced levels of resistant starch may lead to an increase in beneficial gastrointestinal tract bacteria in the large intestine and improved levels of metabolites in animals, such as age-related metabolites in senior animals.
- the term“senior animals” refers to animals that are elderly, which may depend on the breed and species of animal. For example, for certain canines, senior may be defined as at least about 7 years old.
- the pet food compositions disclosed herein may induce an increase in the gastrointestinal tract proportions of the bacterial genera Bifidobacterium and Lactobacillus in animals, such as dogs, while decreasing the relative abundance of Megamonas, a genus consisting largely of disease causing bacteria.
- a method of increasing the proportion of at least one of Lactobacillus and Bifidobacterium in the gastrointestinal tract of an animal comprising feeding the animal a pet food composition as disclosed herein comprising at least about 2.5 g of resistant starch per kg of animal per day.
- a method of decreasing the proportion of Megamonas in the gastrointestinal tract of an animal comprising feeding the animal a pet food composition as disclosed herein comprising at least about 2.5 g of resistant starch per kg of animal per day.
- This shift in the gastrointestinal tract microbiota may be accompanied by improved levels of metabolites associated with age-related health problems. These include, for example, a decline in Advanced Glycation End products (AGEs), such as pyrraline, N6-carboxymethyllysine, and N6-carboxyethyJlysine, and the uremic toxin 3-methyl catechol sulfate. Moreover, the shift in gastrointestinal tract microbiota may further be accompanied by higher levels of dopamine sulfate in the blood of animals, such as senior dogs.
- AGEs Advanced Glycation End products
- AGEs are a complex group of compounds derived from the non-enzymatic glycation of proteins, lipids, and nucleic acids in the body or in exogenous supplies such as food. AGEs cause inflammation and oxidative stress and are implicated in the pathogenesis of several chronic degenerative diseases of aging such as cardiovascular diseases, diabetic complications, renal failure, and cancer.
- the pet food compositions disclosed herein decrease the amounts of at least one of pyrraline, N6-carboxymethylline, and N6-carboxyethyllysine in an animal who consumes the pet food composition.
- the amounts of the at least one of pyrraline, N6-carboxyraethylline, and N6-carboxye ⁇ hyilysine may be measured in the feces of the animal and in certain embodiments it may be measured in the blood of the animal, such as in the serum. Accordingly, disclosed herein is a method of reducing the amount of at least one of pyrraline, N6-carboxymethyiline, and N6-carboxyethyllysine in an animal comprising feeding the animal a pet food composition as disclosed herein, wherein the pet food composition fed to the animal comprises at least about 2.5 g of resistant starch per kg of animal per day. Further disclosed herein are methods of ameliorating chronic degenerative diseases, such as those caused, at least in part, by AGEs, in an animal in need thereof comprising feeding the animal an effective amount of a pet food composition as disclosed herein.
- Uremic toxins are among the major toxic metabolites that lead to various diseases in aging. Although the majority of the uremic toxins originate endogenously from the host metabolism, some originate from fermentation of proteins in the colon by proteolytic bacteria. Products of the putrefaction process are absorbed and converted to toxic derivatives, which can burden kidney function.
- One example of such metabolites is 3-methyl catechol sulfate.
- the pet food compositions disclosed herein decrease the amount of 3-methyl catechol sulfate in an animal that consumes the pet food composition.
- the amounts of the 3-methyl catechol sulfate may be measured in the feces of the animal and in certain embodiments it may be measured in the blood of the animal, such as in the serum.
- methods of ameliorating kidney disease, such as kidney disease caused at least in part by uremic toxins, in an animal in need thereof comprising feeding the animal an effective amount of a pet food composition as disclosed herein.
- the pet food compositions disclosed herein further preserve the bioactive dipeptide carnosine (B-ALA-HIS).
- Camosine has biological activity, acting as an AGE scavenger and decreasing negative health consequences of AGE exposure.
- the pet food compositions disclosed herein increase the amount of carnosine in an animal that consumes the pet food composition.
- the amounts of the carnosine may be measured in the feces of the animal and in certain embodiments it may be measured in the blood of the animal, such as in the serum.
- gastrointestinal tract health important for an animal’s physical well-being, for example in ameliorating chronic degenerative diseases attributed at least in part to AGEs and ameliorating kidney disease attributed at least in part to uremic toxins, but gastrointestinal health is also important to an animal’s mental well-being.
- Gut-brain axis cross talk have shown that changes in the gastrointestinal tract microbiota can either promote or reduce a healthy menial state. It has been shown that, in humans, the level of circulating dopamine sulfate correlates with that of dopamine. (Claustre et ah, Conjugation and deamination of circulating dopamine: relationship between sulfated and free dopamine in man , J. AUTONOMIC NERVOUS SYS. 29(2): 175-181 (1990)) Dopamine is a key neurotransmitter for cognition and is known to decline with age, leading to impaired cognitive function and motor skills.
- Certain foods and ingredients are known to increase the production of circulating dopamine and dopamine sulfate.
- senior dogs who consume the pet food compositions disclosed herein exhibit an increase in their dopamine sulfate levels in their blood, this increase in dopamine sulfate levels may imply the pet food compositions disclosed herein have a positive psychobiotic effect.
- Psychobiotics are substances that exert a microbiome- mediated production of metabolites, which have a psychological effect. (Sarkar et ah, Psychobiotics and the manipulation of bacteria gut-brain signals , TRENDS IN NEUROSCIENCE 39(1 1): 763-781 (2016)) Often the underlying mechanism of action of psychohiotic-derived neurotransmitters is indirect.
- vagus nerve in the gastrointestinal tract allows for action at a distance in the brain.
- Certain gastrointestinal tract bacteria have been reported to produce a range of neurotransmitters, including dopamine, through the metabolism of indigestible fiber. (Sarkar et ah, 2016). Therefore, it is thought that the pet food compositions disclosed herein may lead to an increased level of dopamine by increasing the proportions of Lactobacilli and Bifidobacteria in the gastrointestinal tracts of animals who consume the pet food composition, whereupon vagal stimulation offers opportunity to improved mental state by increasing the blood levels of dopamine sulfate.
- the pet food compositions disclosed herein increase the amount of dopamine sulfate in an animal that consumes the pet food composition.
- the amount of dopamine sulfate may be measured in the blood of the animal, such as in the serum.
- the animal consuming the pet food composition consumes at least about 2.5 g of resistant starch per kg of animal per day, such as between about 2.5 g to about 4.7 g of resistant starch per kg of animal per day.
- the pet food compositions disclosed herein may further comprise additional ingredients, such as fats, carbohydrates, proteins, fibers, and nutritional balancing agents.
- additional fat and carbohydrate ingredient may be obtained from a variety of sources, such as at least one of animal fat, fish oil, vegetable oil, meat, meat by-products, grains, other animal or plant sources.
- the pet food compositions disclosed herein may further comprise at least one protein source.
- suitable protein sources may be selected from any suitable animal or vegetable source.
- suitable protein sources may include at least one of poultry meal, poultry- by-product meal, chicken meal, chicken by-product meal, lamb meal, meat and meat bone, fish meal, soy bean meal, soy protein concentrates, milk proteins, corn gluten meal, wheat gluten, and gluten.
- the starch source may also be a source of protein.
- the pet food compositions disclosed herein may further comprise at least one fiber source.
- Fiber sources may, for example, be chosen from at least one vegetable fiber source, such as cellulose, beet pulp, peanut hulls, and soy fiber.
- the pet food compositions disclosed herein further comprise nutritional balancing agents.
- Nutritional balancing agents may be obtained from a variety of sources known to skilled artisans, for example, vitamin and mineral supplements and food ingredients. Vitamins and minerals can be included in amounts required to avoid deficiencies and maintain health. These amounts are readily available in the art. The American Feed Control Officials (AAFCO) provides recommended amounts of such nutrients for dogs and cats. Vitamins generally useful as food additives include vitamin A, vitamin B i, vitamin B2, vitamin B6, vitamin B12, vitamin D, biotin, vitamin K, folic acid, inositol, niacin, and pantothenic acid.
- the pet food compositions disclosed herein may comprise additional ingredients such as fillers, palatability enhancers, binding agents, flavors, stabilizers, emulsifiers, sweeteners, colorants, buffers, salts, coatings, and the like.
- Stabilizers include substances that tend to increase the shelf life of the compositions such as preservatives, synergists and sequestrants, packaging gases, emulsifiers, thickeners, gelling agents, and humectants.
- emulsifiers and/or thickening agents examples include gelatin, cellulose ethers, starch, starch esters, starch ethers, and modified starches. Specific amounts for each composition component will depend on a variety of factors such as the particular components included in the composition; the species of the animal, the animal’s age, body weight, general health, gender, and diet; the animal’s consumption rate; the type of disease or condition being treated; and the like.
- the pet food compositions disclosed herein may be made by an optimized extrusion method for producing pet food compositions comprising an enhanced amount of resistant starch.
- the extrusion methods disclosed herein result in a pet food composition that, due to its enhanced levels of resistant starch, increases the levels of colonic lactate by improving redox balance, while concurrently decreasing AGEs and uremic toxins associated with detrimental health outcomes and increasing the levels of dopamine, resulting in potentially beneficial psychobiotie effects.
- the extrusion method disclosed herein minimizes the destruction of resistant starch and plant botanicals to allow for delivery of energy substrates to the lower intestinal tract of animals, such as dogs, for metabolism by commensal gastrointestinal microbiota to beneficial lactates.
- the novel extrusion methods disclosed herein also produce a food composition that allows, inter alia , for an increased preservation of camosine and decreases the processing-related AGE formation.
- high blood glucose levels from the digestion of non-resistant starch in the small intestine may promote endogenous formation of AGE products. Accordingly, the extrusion methods disclosed herein, which result in a pet food composition having enhanced levels of resistant starch, also lowers the levels of AGE products produced by an animal consuming the pet food composition.
- Food extrusion devices may comprise a preconditioner interconnected to a single, elongated, tubular extruder barrel having an output comprising a die at an end opposite the preconditioner.
- the die coupled with the output end of the extruder barrel functions to form the shape of the end-product food, such as the kibble, as it emerges from the extruder barrel.
- Inside the extrader barrel is a single or twin screw, which functions to apply shear forces and convey the food composition forward and through the extruder barrel towards the output and through the die. Steam may be injected into the preconditioner and/or the extruder barrel during processing.
- pet food raw materials are fed into a preconditioner, wherein liquid, which may include, for example, water, oil, and steam, are added.
- liquid which may include, for example, water, oil, and steam
- the preconditioned raw materials may be partially cooked.
- the raw materials are mixed and preconditioned to form a dough.
- Raw materials may comprise any of the ingredients disclosed above, in addition to and include the source of the resistant starch, such as, for example, fats, carbohydrates, proteins, fibers, and nutritional balancing agents.
- the dough is directed into the extrader barrel. In certain embodiments, no additional steam is added when the dough is directed into the extrader barrel.
- the dough is subjected to the rotating single or twin screw. Inside the extrader barrel, the dough may be subjected to varying levels of temperature, pressure, and shear, all of which may affect the resultant food product.
- the screw may operate at an RPM of less than about 500 RPMs, such less than about 400 RPMs, less than about 300 RPMs, about 270 RPMs, or a range of from about 250 RPMs to about 300 RPMs.
- the extruder barrel may be operated to have a flow rate greater than about 1,000 kg/h, such as greater than about 1,500 kg/h, about 1,800 kg/h, or ranging from about 1,500 kg/h to about 2,000 kg/h.
- the dough As the dough emerges out of the extruder barrel from the die, it may be formed into the final pet food composition product, such as a kibble or other desired shape.
- the final pet food composition may also expand to a certain degree, which may depend upon many factors, including the amount of energy imparted to the food composition in the extruder barrel, the amount of moisture in the food composition, and the shape of the die.
- SME Specific Mechanical Energy
- SME refers to a measure of the mechanical energy put into the extradate in an extruder device, for example from the motor of the extruder.
- SME is a measure of the energy going into the extrusion system per unit mass and may be measured, for example, in terms of Wh/kg.
- SME may range from about 40 Wh/kg to about 50 Wh/kg, such as from about 48 W h/kg, or, for example, more than about 40 W h/kg or more than about 45 Wh/kg.
- the SME may be less than about 40 Wh/kg, such as less than about 30 Wh/kg, less than about 25 Wh/kg, less than about 20 Wh/kg, less than about 15 W h/kg, or about 10 Wh/kg. In certain embodiments, for low shear mixing, the SME may range from about 10 W h/kg to about 40 W h/kg, such as from about 10 W h/kg to about 15 W h/kg. Under the low shear mixing conditions disclosed herein, the pet food composition retains enhanced levels of resistant starch, such as, for example, at least about 7% resistant starch based on the total amount of the pet food composition
- the term“Specific Thermal Energy” refers to the energy in the form of heat, such as from steam, put into the extrudate in an extruder device.
- STE is a measure of the energy going into the extrusion system per unit mass and may be measured, for example, in terms of Wh/kg.
- Wh/kg In a typical extrusion process involving high shear mixing, STE may range from about 40 Wh/kg to about 50 W h/kg, such as from about 40 Wh/kg to about 45 Wh/kg or, in certain embodiments of a typical extrusion process, the STE may be at least about 40 W h/kg.
- the ratio of the SME to STE may be approximately 1, and in certain food extrusion processes involving high shear mixing, the ratio of the SME to STE may be greater than 1.
- the STE may range from about 40 Wh/kg to about 50 W h/kg, such as from about 40 W h/kg to about 45 W h/kg or about 42 Wh/kg or, in certain embodiments, less than about 45 Wh/kg.
- the ratio of the SME to STE is less than 1, such as less than about 0.5, less than about 0.33, or less than about 0 25.
- the sum of the specific mechanical energy and the specific thermal energy of the extrusion device may be less than about 100 W h/kg, such as less than about 75 W h/kg, less than about 60 Wh/kg, less than about 50 Wh/kg, or less than about 60 Wh/kg.
- the barrel temperature of the extruder barrel may range fro about 70 °C to about 125 °C.
- the extruder device may, in certain embodiments, further comprise a back pressure valve operably connected to the extruder barrel that can range from 0% open (fully closed) to 100% open (fully open). In certain embodiments disclosed herein, the back pressure valve is closed
- a pet food composition using low shear extrusion parameters comprising providing pet food raw' materials for extrusion and extruding the raw materials using an extrusion device.
- the raw materials are first preconditioned into a dough.
- the specific mechanical energy of the extrusion device is less than about 25 W h/kg and the pet food composition produced by the extrusion method results in a pet food composition comprising resistant starch in an amount of at least about 7% by weight based on the total weight of the pet food composition
- extruded pet food compositions comprising resistant starch in an amount of at least about 7%, such as about 7% to about 30%, at least about 10%, about 9% to about 13%, or about 7% to about 20%, by weight based on the total weight of the pet food composition.
- the term“extruded pet food composition” refers to a pet food composition formulated from raw' pet food materials that have been processed in an extrusion device using specific mechanical and thermal energy.
- an animal consuming a pet food composition as disclosed herein may consume the pet food composition in an amount of at least about 2.5 g of resistant starch, such as at least about 3 g, at least about 3.5 g, at least about 4 g, at least about 4.5 g, or at least about 5 g of resistant starch per kg of animal per day.
- a pet food composition as disclosed herein in an amount of at least about 2.5 g of resistant starch, such as at least about 3 g, at least about 3 5 g, at least about 4 g, or at least about 4.5 g, of resistant starch per kg of animal per day.
- a pet food composition as disclosed herein in an amount of at least about 2.5 g of resistant starch, such as at least about 3 g, at least about 3.5 g, at least about 4 g, at least about 4.5 g, at least about 5 g, at least about 5.5 g, at least about 6 g, or at least about 7 g of resistant starch per kg of animal per day.
- the pet food compositions disclosed herein can be fabricated into any form desired, including, for example, kibbles, biscuits, and snack products.
- a Test Diet and a Control Diet were formulated according to the American Association of Feed Control Officials (AAFCO) nutrition recommendations. The formulations were produced by extrusion, dried, and coated with palatants. Both the Test Diet and the Control Diet were a simple canine maintenance formulation and were the same formulation, as shown below in Table 1.
- the kibbles were prepared under high shear extrusion parameters.
- the raw ingredients were fed into a preconditioner wherein steam was added at 73.2 kg/h and 11 % steam pressure (SP), achieving a temperature of 98.8 °C at the end of the preconditioner. Water content was 27.5% with a preconditioner processing rate of 858.4 kg/h.
- the preconditioned dough was then fed into the extrusion barrel, wherein the screw operated at 500 RPM at a 55% load.
- the temperature in the extrusion barrel varied from 69.4 °C to 142 8 °C. No steam was added to the extrusion barrel, resulting in flow rate of 858.4 kg/h in the barrel at
- the back pressure valve was closed (0% open), and the temperature at the die output was 131.6 °C, resulting in -44.2 kg/h steam evaporation and a kibble product of 23 5% I3 ⁇ 40.
- the Specific Mechanical Energy (SME) for the high shear parameters was calculated to be 48 Wh/kg, and the Specific Thermal Energy (STE) was calculated to be 41 W h/kg, for a Total Energy of 89 Wh/kg.
- the kibbles were prepared under low shear extrusion parameters.
- the raw ingredients were fed into a preconditioner wherein steam 'as added at 138.8 kg/h and 10 % SP, achieving a temperature of 101.3 °C.
- Water content was 25.0% at a rate of 1,827.5 kg/h.
- the preconditioned dough was then fed into the extrusion barrel, wherein the screw operated at 270 RPM at a 24% load.
- the temperature in the extrusion barrel varied from 71.7 °C to 123.7 °C. No steam was added to the extrusion barrel, resulting in flow ' rate of 1,827.5 kg/h in the barrel and a moisture content of 25 0% H 2 0.
- the back pressure valve was 100% open, and the temperature at the die output was 110.5 °C, resulting in -50.0 kg/h steam evaporation and a kibble product of 22 9% H 2 0.
- the SME for the low shear parameters was calculated to be 10 W h/kg, and the STE was calculated to be 42 Wh/kg, for a Total Energy of 51 W h/kg. Accordingly, there was approximately a 4-fold reduction in Mechanical Shear Energy (MSE) under the low shear parameters for the Test Diet as compared to the high shear parameters for the Control Diet.
- MSE Mechanical Shear Energy
- Control Diet Based on the high shear extrusion parameters used to produce the Control Diet, it is estimated that the Control Diet comprised about 2% by weight of resistant starch. Based on the low shear extrusion parameters used to produce the Test Diet, it is estimated that the Test Diet comprised about 28% by weight of resistant starch.
- an IACUC-approved clinical dietary intervention protocol was implemented which enrolled healthy canine subjects randomized to two groups based on age, weight, and gender. Canines were assessed by blood and fecal markers of biochemical and clinical health. The study was a caretaker-blinded, longitudinal design.
- Stools were collected after six weeks of consuming the Control and Test Diets. Stools were assessed by Hill’s Visual Stool Scale, which ranks the subjective desirability of stools from essentially liquid (Score 1) to exemplarily firm (Score 5). After scoring, within 30 minutes of defecation the stools were homogenized extensively and then portions were ali quoted into cryo containers before being flash frozen into liquid nitrogen for metabolic endpoints (e.g., lactates, pyruvates, AGE, carnosine).
- metabolic endpoints e.g., lactates, pyruvates, AGE, carnosine
- Test Diet differed from the Control Diet by the 4-fold reduction in Mechanical Shear Energy, which resulted in a dramatic preservation of resistant starch. See the Relative Viscosity Analysis at Figure 1.
- the food was analyzed and found to be equivalent in terms of protein, fat, fiber, moisture, ash, and energy density. See Table 2 below.
- Digestibility of the Test Diet was essentially equivalent to the Control Diet, except for about a 2% decrease in protein digestibility, as shown in Table 3 below. Additionally, it may be noted that the digestibility of fiber in the test diet was increased over digestibility of fiber in the control diet. This increase may indicate that the process used to prepare the test diet resulted in fiber that had an increased fermentability by gut bacteria.
- the Test Diet contained brewer’s rice and corn as the sole sources of grain at a ratio of approximately 1 :5.
- the Control Diet contained a variety of whole grains such as sorghum, wheat, barley, and oat, as well as 20% of the corn in the Test Food.
- the two diets had a similar nutrient profile except for the grains, as shown below in Table 9
- the percent cook of the Test Diet was shown to be about 80%, with the remaining 20% being uncooked, resistant starch.
- the percent cook of the Control Diet was shown to be about 90%, with the remaining 10% being uncooked, resistant starch. Accordingly, the cooked proportions of the Test Diet and the Control Diet were approximately 0 8 and 0.9, respectively. This leaves the proportions of resistant starch in the Test and the Control Diets to be approximately 0.2 and 0.1, respectively.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17822840.9A EP3720290A1 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
PCT/US2017/064677 WO2019112562A1 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
MX2020005631A MX2020005631A (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch. |
CA3081943A CA3081943A1 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
US16/769,465 US11751583B2 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
JP2020530686A JP7160920B2 (en) | 2017-12-05 | 2017-12-05 | Pet Food Compositions Containing Enhanced Levels of Resistant Starch, and Methods of Making Pet Food Compositions |
AU2017442089A AU2017442089B2 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2017/064677 WO2019112562A1 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019112562A1 true WO2019112562A1 (en) | 2019-06-13 |
Family
ID=60888612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2017/064677 WO2019112562A1 (en) | 2017-12-05 | 2017-12-05 | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch |
Country Status (7)
Country | Link |
---|---|
US (1) | US11751583B2 (en) |
EP (1) | EP3720290A1 (en) |
JP (1) | JP7160920B2 (en) |
AU (1) | AU2017442089B2 (en) |
CA (1) | CA3081943A1 (en) |
MX (1) | MX2020005631A (en) |
WO (1) | WO2019112562A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115087360A (en) * | 2020-02-10 | 2022-09-20 | 马斯公司 | Low moisture extrusion process |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2023290156A1 (en) * | 2022-06-15 | 2024-11-21 | Hill's Pet Nutrition, Inc. | Pet food compositions and method for reducing metabolites associated with protein putrefaction in a feline |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070092620A1 (en) * | 2005-10-26 | 2007-04-26 | Zimeri Jeanny E | Production of low calorie, extruded, expanded foods having a high fiber content |
US20120251659A1 (en) * | 2011-03-31 | 2012-10-04 | Brunob Ii B.V. | Use of Extruded Starch-Based Complexes for Satiety, Reduction of Food Intake, and Weight Management |
WO2016130981A1 (en) * | 2015-02-13 | 2016-08-18 | Mars, Incorporated | Pet food feeding system |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0675690A4 (en) | 1992-12-24 | 1997-02-26 | Goodman Fielder Ltd | Food compositions including resistant starch. |
AU664327C (en) | 1993-03-24 | 2003-01-30 | Brunob Ii B.V. | Method for increasing expansion and improving texture of fiber fortified extruded food products |
US20060193959A1 (en) * | 2002-10-30 | 2006-08-31 | Li Nie | Low calorie injection molded starch-based pet chew bodies |
US7252836B2 (en) * | 2003-01-13 | 2007-08-07 | Penwest, Ltd. | Food and feed compositions including resistant starch |
US8993039B2 (en) | 2006-01-25 | 2015-03-31 | Tate & Lyle Ingredients Americas Llc | Fiber-containing carbohydrate composition |
WO2011011472A1 (en) * | 2009-07-21 | 2011-01-27 | Hill's Pet Nutrition, Inc. | Companion animal nutrition system |
TW201427604A (en) * | 2013-01-03 | 2014-07-16 | Shi-Chuang Lin | Manufacturing method of whole grain powder and whole grain powder product |
JP5848275B2 (en) * | 2013-03-08 | 2016-01-27 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | Compositions and methods for reducing fecal volume and fecal odor |
WO2015073772A1 (en) | 2013-11-14 | 2015-05-21 | Danisco Us Inc. | Stable enzymes by glycation reduction |
AU2015319791A1 (en) * | 2014-09-19 | 2017-02-23 | Nestec Sa | Treatment of cancer with alpha-amylase inhibitor in companion animals |
-
2017
- 2017-12-05 US US16/769,465 patent/US11751583B2/en active Active
- 2017-12-05 CA CA3081943A patent/CA3081943A1/en active Pending
- 2017-12-05 EP EP17822840.9A patent/EP3720290A1/en active Pending
- 2017-12-05 JP JP2020530686A patent/JP7160920B2/en active Active
- 2017-12-05 MX MX2020005631A patent/MX2020005631A/en unknown
- 2017-12-05 AU AU2017442089A patent/AU2017442089B2/en active Active
- 2017-12-05 WO PCT/US2017/064677 patent/WO2019112562A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070092620A1 (en) * | 2005-10-26 | 2007-04-26 | Zimeri Jeanny E | Production of low calorie, extruded, expanded foods having a high fiber content |
US20120251659A1 (en) * | 2011-03-31 | 2012-10-04 | Brunob Ii B.V. | Use of Extruded Starch-Based Complexes for Satiety, Reduction of Food Intake, and Weight Management |
WO2016130981A1 (en) * | 2015-02-13 | 2016-08-18 | Mars, Incorporated | Pet food feeding system |
Non-Patent Citations (5)
Title |
---|
CLAUSTRE ET AL.: "Conjugation and deamination of circulating dopamine: relationship between sulfated and free dopamine in man", J. AUTONOMIC NERVOUS SYS., vol. 29, no. 2, 1990, pages 175 - 181, XP024531938, DOI: doi:10.1016/0165-1838(90)90183-J |
KLEESSEN B ET AL: "FEEDING RESISTANT STARCH AFFECTS FECAL AND CECAL MICROFLORA ANS SHORT-CHAIN FATTY ACIDS IN RATS", JOURNAL OF ANIMAL SCIENCE, AMERICAN SOCIETY OF ANIMAL SCIENCE, US, vol. 75, no. 9, 1 January 1997 (1997-01-01), pages 2453 - 2462, XP001180276, ISSN: 0021-8812 * |
M. C. PEIXOTO ET AL: "Effect of resistant starch on the intestinal health of old dogs: fermentation products and histological features of the intestinal mucosa", JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION., vol. 102, no. 1, 26 April 2017 (2017-04-26), DE, pages e111 - e121, XP055487136, ISSN: 0931-2439, DOI: 10.1111/jpn.12711 * |
MATTHEW R. PANASEVICH ET AL: "Modulation of the faecal microbiome of healthy adult dogs by inclusion of potato fibre in the diet", BRITISH JOURNAL OF NUTRITION, vol. 113, no. 01, 1 January 2015 (2015-01-01), UK, pages 125 - 133, XP055487181, ISSN: 0007-1145, DOI: 10.1017/S0007114514003274 * |
SARKAR ET AL.: "Psychobiotics and the manipulation of bacteria gut-brain signals", TRENDS IN NEUROSCIENCE, vol. 39, no. 11, 2016, pages 763 - 781, XP029802741, DOI: doi:10.1016/j.tins.2016.09.002 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115087360A (en) * | 2020-02-10 | 2022-09-20 | 马斯公司 | Low moisture extrusion process |
JP2023513874A (en) * | 2020-02-10 | 2023-04-04 | マース インコーポレーテッド | Low moisture extrusion method |
Also Published As
Publication number | Publication date |
---|---|
JP7160920B2 (en) | 2022-10-25 |
AU2017442089A1 (en) | 2020-07-23 |
US11751583B2 (en) | 2023-09-12 |
JP2021505146A (en) | 2021-02-18 |
US20210186056A1 (en) | 2021-06-24 |
AU2017442089B2 (en) | 2021-06-03 |
CA3081943A1 (en) | 2019-06-13 |
MX2020005631A (en) | 2020-08-20 |
EP3720290A1 (en) | 2020-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Di Cerbo et al. | Functional foods in pet nutrition: Focus on dogs and cats | |
Carciofi et al. | Effects of six carbohydrate sources on dog diet digestibility and post‐prandial glucose and insulin response | |
WO2004107878A1 (en) | High protein, low carbohydrate pet food composition comprising non-fermentable fiber | |
US11944653B2 (en) | Compositions and methods for diagnosing and treating degenerative mitral valve disease in a canine | |
Adolphe et al. | Effect of an extruded pea or rice diet on postprandial insulin and cardiovascular responses in dogs | |
Pacheco et al. | Citrus pulp and orange fiber as dietary fiber sources for dogs | |
JP2024160396A (en) | Pet food composition for weight management in pets suffering from adverse food reactions - Patents.com | |
US20030068390A1 (en) | Method of feeding a ruminant | |
US20220394999A1 (en) | Pet Food Compositions | |
Venturini et al. | Processing traits and digestibility of extruded dog foods with soy protein concentrate | |
EP2352387B1 (en) | Method for modifying fat digestibility | |
AU2017442089B2 (en) | Pet food composition and method of making pet food composition comprising enhanced levels of resistant starch | |
Di Santo et al. | Feed processing effects on digestibility, palatability, excreta fermentation products and blood parameters in blue‐fronted amazon parrots (Amazona aestiva) | |
JP2022515737A (en) | Pet food composition containing insoluble fiber containing lignin, a source of polyphenols, and a source of soluble fiber | |
Holt et al. | Evaluation of Torula yeast as a protein source in extruded feline diets | |
Zoran | Nutritional management of feline gastrointestinal diseases | |
Smith et al. | Evaluation of corn-fermented protein as a dietary ingredient in extruded dog and cat diets | |
Inal et al. | Barley as an alternative to rice in dog food | |
Saadi et al. | The effects of dietary addition of acetic acid on milk yield and composition in Awassi ewes at an early stage of lactation | |
Amornthewaphat et al. | Extrusion and animal performance effects of extruded maize quality on digestibility and growth performance in rats and nursery pigs | |
EP3537889B1 (en) | Pet food compositions | |
Carroll et al. | Examining feed preference of different pellet formulations for application to automated milking systems | |
Corsato Alvarenga et al. | Processing of corn-based dog foods through pelleting, baking and extrusion and their effect on apparent total tract digestibility and colonic health of adult dogs | |
Thonney et al. | Fermentable fiber for diet formulation | |
Rodrigues et al. | Carcass traits and short-chain fatty acid profile in cecal digesta of piglets fed alfalfa hay and fructooligosaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17822840 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3081943 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2020530686 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2017822840 Country of ref document: EP Effective date: 20200706 |
|
ENP | Entry into the national phase |
Ref document number: 2017442089 Country of ref document: AU Date of ref document: 20171205 Kind code of ref document: A |